When you buy through links on our articles, Future and its syndication partners may earn a commission. POLG-related diseases are a diverse family of conditions all caused by mutations in a gene for a ...

Mitochondrial diseases (MD) remain an urgent clinical challenge due to the lack of reliable biomarkers and effective therapies. Patients often go undiagnosed until severe tissue failure occurs, and ...

For the first time, a synthetic compound has been made that can bind to DNA in the cells' energy powerhouses, suppressing a gene associated with nerve and muscle disease. Pyrrole-imidazole polyamides ...

Just a few days after scientists announced we're at a pivotal tipping point in Alzheimer's disease research, a team has made a huge breakthrough, proving for the first time how mitochondrial ...

Short facts about the study: basic research // preclinical, quantitative study // in vitro with cell samples from cancer patients // A new study led by researchers at Lund University in Sweden, ...

21 November 2024 – The United Mitochondrial Disease Foundation’s (UMDF) venture philanthropy arm, The Mito Fund, has invested in Khondrion, a Netherlands-based clinical stage biopharmaceutical company ...